Studying severe COPD in Brazil
Part of Lungs & breathing clinical trials.
This study follows people with severe or very severe COPD to learn more about their health over time. You may qualify if your COPD causes many symptoms or frequent flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe or very severe COPD based on lung function tests (FEV1 less than 50% of normal)
- You have had at least 2 moderate flare-ups or 1 severe flare-up in the past year
- Your symptoms make basic activities hard (like walking or dressing)
- You do not have severe lung scarring or pulmonary hypertension needing triple therapy
- You do not have active cancer that requires chemotherapy, radiation, or other systemic treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a triple inhaler (BDP/FF/GB) works for people with severe COPD in Brazil. It may help those who have had at least one flare-up in the past year.
This study looks at the health of Brazilian adults with COPD. It aims to understand how the condition affects people and may help improve future treatments.
This trial looks at how long-term health conditions like heart disease, diabetes, or high blood pressure might affect breathing problems. The goal is to better understand and help people with both issues.
This study looks at how to better manage chronic diseases like lung problems along with other ongoing conditions. It may test a simple breathing test at your primary health center to find lung issues early.
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
This study is observing people with severe COPD to learn more about how the disease progresses. By participating, you help researchers understand severe COPD better, which may lead to improved care for others.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.